Conceptualizing Overdiagnosis in Cancer Screening
The aim of cancer screening is to detect asymptomatic cancers whose treatment will result in extension of life, relative to length of life absent screening. Unfortunately, cancer screening also results in overdiagnosis, the detection of cancers that, in the absence of screening, would not present sy...
Gespeichert in:
Veröffentlicht in: | JNCI : Journal of the National Cancer Institute 2015-04, Vol.107 (4), p.1 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 4 |
container_start_page | 1 |
container_title | JNCI : Journal of the National Cancer Institute |
container_volume | 107 |
creator | Marcus, Pamela M Prorok, Philip C Miller, Anthony B DeVoto, Emily J Kramer, Barnett S |
description | The aim of cancer screening is to detect asymptomatic cancers whose treatment will result in extension of life, relative to length of life absent screening. Unfortunately, cancer screening also results in overdiagnosis, the detection of cancers that, in the absence of screening, would not present symptomatically during one's lifetime. Thus, their detection and subsequent treatment is unnecessary and detrimental. This definition of overdiagnosis, while succinct, does not capture the ways it can occur, and our interactions with patients, advocates, researchers, clinicians, and journalists have led us to believe that the concept of overdiagnosis is difficult to explain and, for some, difficult to accept. We propose a dichotomy, the "tumor-patient" classification, to aid in understanding overdiagnosis. The tumor category includes asymptomatic malignant disease that would regress spontaneously if left alone, as well as asymptomatic malignant disease that stagnates or progresses too slowly to be life threatening in even the longest of lifetimes. The patient category includes asymptomatic malignant disease that would progress quickly enough to be life threatening during a lifetime of typical length, but lacks clinical relevance because death due to another cause intercedes prior to what would have been the date of symptomatic diagnosis had screening not occurred. Cancer screening of most organs is likely to result in overdiagnosis of both types. However, the ratio of tumor- to patient-driven overdiagnosis almost certainly varies, and may vary drastically, by organ, screening modality, patient characteristics, and other factors. |
format | Article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_1675779334</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3665885961</sourcerecordid><originalsourceid>FETCH-proquest_journals_16757793343</originalsourceid><addsrcrecordid>eNpjYuA0NDEz0DUyNDBlYeA0MDAy17WwMDfhYOAqLs4yAAJLIxNOBkPn_Lzk1IKS0sSczKrMvHQF_7LUopTMxPS8_OLMYoXMPAXnRKCCIoXg5KLU1DygCh4G1rTEnOJUXijNzaDs5hri7KFbUJRfWJpaXBKflV9alAeUijc0Mzc1N7c0NjYxJk4VAK9WNSE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1675779334</pqid></control><display><type>article</type><title>Conceptualizing Overdiagnosis in Cancer Screening</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Marcus, Pamela M ; Prorok, Philip C ; Miller, Anthony B ; DeVoto, Emily J ; Kramer, Barnett S</creator><creatorcontrib>Marcus, Pamela M ; Prorok, Philip C ; Miller, Anthony B ; DeVoto, Emily J ; Kramer, Barnett S</creatorcontrib><description>The aim of cancer screening is to detect asymptomatic cancers whose treatment will result in extension of life, relative to length of life absent screening. Unfortunately, cancer screening also results in overdiagnosis, the detection of cancers that, in the absence of screening, would not present symptomatically during one's lifetime. Thus, their detection and subsequent treatment is unnecessary and detrimental. This definition of overdiagnosis, while succinct, does not capture the ways it can occur, and our interactions with patients, advocates, researchers, clinicians, and journalists have led us to believe that the concept of overdiagnosis is difficult to explain and, for some, difficult to accept. We propose a dichotomy, the "tumor-patient" classification, to aid in understanding overdiagnosis. The tumor category includes asymptomatic malignant disease that would regress spontaneously if left alone, as well as asymptomatic malignant disease that stagnates or progresses too slowly to be life threatening in even the longest of lifetimes. The patient category includes asymptomatic malignant disease that would progress quickly enough to be life threatening during a lifetime of typical length, but lacks clinical relevance because death due to another cause intercedes prior to what would have been the date of symptomatic diagnosis had screening not occurred. Cancer screening of most organs is likely to result in overdiagnosis of both types. However, the ratio of tumor- to patient-driven overdiagnosis almost certainly varies, and may vary drastically, by organ, screening modality, patient characteristics, and other factors.</description><identifier>ISSN: 0027-8874</identifier><identifier>EISSN: 1460-2105</identifier><identifier>CODEN: JNCIEQ</identifier><language>eng</language><publisher>Oxford: Oxford Publishing Limited (England)</publisher><subject>Asymptotic methods ; Cancer ; Medical diagnosis ; Medical screening ; Oncology ; Tumors</subject><ispartof>JNCI : Journal of the National Cancer Institute, 2015-04, Vol.107 (4), p.1</ispartof><rights>Copyright Oxford Publishing Limited(England) Apr 2015</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids></links><search><creatorcontrib>Marcus, Pamela M</creatorcontrib><creatorcontrib>Prorok, Philip C</creatorcontrib><creatorcontrib>Miller, Anthony B</creatorcontrib><creatorcontrib>DeVoto, Emily J</creatorcontrib><creatorcontrib>Kramer, Barnett S</creatorcontrib><title>Conceptualizing Overdiagnosis in Cancer Screening</title><title>JNCI : Journal of the National Cancer Institute</title><description>The aim of cancer screening is to detect asymptomatic cancers whose treatment will result in extension of life, relative to length of life absent screening. Unfortunately, cancer screening also results in overdiagnosis, the detection of cancers that, in the absence of screening, would not present symptomatically during one's lifetime. Thus, their detection and subsequent treatment is unnecessary and detrimental. This definition of overdiagnosis, while succinct, does not capture the ways it can occur, and our interactions with patients, advocates, researchers, clinicians, and journalists have led us to believe that the concept of overdiagnosis is difficult to explain and, for some, difficult to accept. We propose a dichotomy, the "tumor-patient" classification, to aid in understanding overdiagnosis. The tumor category includes asymptomatic malignant disease that would regress spontaneously if left alone, as well as asymptomatic malignant disease that stagnates or progresses too slowly to be life threatening in even the longest of lifetimes. The patient category includes asymptomatic malignant disease that would progress quickly enough to be life threatening during a lifetime of typical length, but lacks clinical relevance because death due to another cause intercedes prior to what would have been the date of symptomatic diagnosis had screening not occurred. Cancer screening of most organs is likely to result in overdiagnosis of both types. However, the ratio of tumor- to patient-driven overdiagnosis almost certainly varies, and may vary drastically, by organ, screening modality, patient characteristics, and other factors.</description><subject>Asymptotic methods</subject><subject>Cancer</subject><subject>Medical diagnosis</subject><subject>Medical screening</subject><subject>Oncology</subject><subject>Tumors</subject><issn>0027-8874</issn><issn>1460-2105</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNpjYuA0NDEz0DUyNDBlYeA0MDAy17WwMDfhYOAqLs4yAAJLIxNOBkPn_Lzk1IKS0sSczKrMvHQF_7LUopTMxPS8_OLMYoXMPAXnRKCCIoXg5KLU1DygCh4G1rTEnOJUXijNzaDs5hri7KFbUJRfWJpaXBKflV9alAeUijc0Mzc1N7c0NjYxJk4VAK9WNSE</recordid><startdate>20150401</startdate><enddate>20150401</enddate><creator>Marcus, Pamela M</creator><creator>Prorok, Philip C</creator><creator>Miller, Anthony B</creator><creator>DeVoto, Emily J</creator><creator>Kramer, Barnett S</creator><general>Oxford Publishing Limited (England)</general><scope>7TO</scope><scope>7U7</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20150401</creationdate><title>Conceptualizing Overdiagnosis in Cancer Screening</title><author>Marcus, Pamela M ; Prorok, Philip C ; Miller, Anthony B ; DeVoto, Emily J ; Kramer, Barnett S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_16757793343</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Asymptotic methods</topic><topic>Cancer</topic><topic>Medical diagnosis</topic><topic>Medical screening</topic><topic>Oncology</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Marcus, Pamela M</creatorcontrib><creatorcontrib>Prorok, Philip C</creatorcontrib><creatorcontrib>Miller, Anthony B</creatorcontrib><creatorcontrib>DeVoto, Emily J</creatorcontrib><creatorcontrib>Kramer, Barnett S</creatorcontrib><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><jtitle>JNCI : Journal of the National Cancer Institute</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Marcus, Pamela M</au><au>Prorok, Philip C</au><au>Miller, Anthony B</au><au>DeVoto, Emily J</au><au>Kramer, Barnett S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Conceptualizing Overdiagnosis in Cancer Screening</atitle><jtitle>JNCI : Journal of the National Cancer Institute</jtitle><date>2015-04-01</date><risdate>2015</risdate><volume>107</volume><issue>4</issue><spage>1</spage><pages>1-</pages><issn>0027-8874</issn><eissn>1460-2105</eissn><coden>JNCIEQ</coden><abstract>The aim of cancer screening is to detect asymptomatic cancers whose treatment will result in extension of life, relative to length of life absent screening. Unfortunately, cancer screening also results in overdiagnosis, the detection of cancers that, in the absence of screening, would not present symptomatically during one's lifetime. Thus, their detection and subsequent treatment is unnecessary and detrimental. This definition of overdiagnosis, while succinct, does not capture the ways it can occur, and our interactions with patients, advocates, researchers, clinicians, and journalists have led us to believe that the concept of overdiagnosis is difficult to explain and, for some, difficult to accept. We propose a dichotomy, the "tumor-patient" classification, to aid in understanding overdiagnosis. The tumor category includes asymptomatic malignant disease that would regress spontaneously if left alone, as well as asymptomatic malignant disease that stagnates or progresses too slowly to be life threatening in even the longest of lifetimes. The patient category includes asymptomatic malignant disease that would progress quickly enough to be life threatening during a lifetime of typical length, but lacks clinical relevance because death due to another cause intercedes prior to what would have been the date of symptomatic diagnosis had screening not occurred. Cancer screening of most organs is likely to result in overdiagnosis of both types. However, the ratio of tumor- to patient-driven overdiagnosis almost certainly varies, and may vary drastically, by organ, screening modality, patient characteristics, and other factors.</abstract><cop>Oxford</cop><pub>Oxford Publishing Limited (England)</pub></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0027-8874 |
ispartof | JNCI : Journal of the National Cancer Institute, 2015-04, Vol.107 (4), p.1 |
issn | 0027-8874 1460-2105 |
language | eng |
recordid | cdi_proquest_journals_1675779334 |
source | Oxford University Press Journals All Titles (1996-Current); Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
subjects | Asymptotic methods Cancer Medical diagnosis Medical screening Oncology Tumors |
title | Conceptualizing Overdiagnosis in Cancer Screening |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T16%3A51%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Conceptualizing%20Overdiagnosis%20in%20Cancer%20Screening&rft.jtitle=JNCI%20:%20Journal%20of%20the%20National%20Cancer%20Institute&rft.au=Marcus,%20Pamela%20M&rft.date=2015-04-01&rft.volume=107&rft.issue=4&rft.spage=1&rft.pages=1-&rft.issn=0027-8874&rft.eissn=1460-2105&rft.coden=JNCIEQ&rft_id=info:doi/&rft_dat=%3Cproquest%3E3665885961%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1675779334&rft_id=info:pmid/&rfr_iscdi=true |